Literature DB >> 26975730

Management of uveal tract melanoma: A comprehensive review.

Akhil Kapoor1, Vimla Beniwal2, Surender Beniwal3, Harsh Mathur4, Harvindra Singh Kumar5.   

Abstract

Uveal tract melanoma is the most common primary intraocular malignancy in adults, accounting for about 5-10% of all the melanomas. Since there are no lymphatic vessels in the eye, uveal melanoma can only spread hematogenously leading to liver metastasis. A wide variety of treatment modalities are available for its management, leading to dilemma in selecting the appropriate therapy. This article reviews the diagnostic and therapeutic modalities available and thus, can help to individualize the treatment plan for each patient.
Copyright © 2016 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Management; Treatment modalities; Uveal tract melanoma

Mesh：

Year:  2016        PMID： 26975730     DOI： 10.1016/j.jnci.2016.02.003

Source DB:  PubMed          Journal:  J Egypt Natl Canc Inst        ISSN： 1110-0362


  7 in total

1.  Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.

Authors:  Bum-Sup Jang; Ji Hyun Chang; Sohee Oh; Yu Jin Lim; Il Han Kim
Journal:  Strahlenther Onkol       Date:  2017-09-06       Impact factor: 3.621

Review 2.  Imaging of Uveal Melanoma-Current Standard and Methods in Development.

Authors:  Małgorzata Solnik; Natalia Paduszyńska; Anna M Czarnecka; Kamil J Synoradzki; Yacoub A Yousef; Tomasz Chorągiewicz; Robert Rejdak; Mario Damiano Toro; Sandrine Zweifel; Katarzyna Dyndor; Michał Fiedorowicz
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

Review 3.  Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging-Part II: treatment indications and complications.

Authors:  Pietro Valerio Foti; Mario Travali; Renato Farina; Stefano Palmucci; Corrado Spatola; Rocco Luca Emanuele Liardo; Roberto Milazzotto; Luigi Raffaele; Vincenzo Salamone; Rosario Caltabiano; Giuseppe Broggi; Lidia Puzzo; Andrea Russo; Michele Reibaldi; Antonio Longo; Paolo Vigneri; Teresio Avitabile; Giovani Carlo Ettorre; Antonio Basile
Journal:  Insights Imaging       Date:  2021-06-04

Review 4.  Diagnostic methods and therapeutic options of uveal melanoma with emphasis on MR imaging-Part I: MR imaging with pathologic correlation and technical considerations.

Authors:  Pietro Valerio Foti; Mario Travali; Renato Farina; Stefano Palmucci; Corrado Spatola; Luigi Raffaele; Vincenzo Salamone; Rosario Caltabiano; Giuseppe Broggi; Lidia Puzzo; Andrea Russo; Michele Reibaldi; Antonio Longo; Paolo Vigneri; Teresio Avitabile; Giovani Carlo Ettorre; Antonio Basile
Journal:  Insights Imaging       Date:  2021-06-03

5.  Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma.

Authors:  Wen-Da Zhou; Lei Shao; Li Dong; Rui-Heng Zhang; Yi-Fan Li; He-Yan Li; Hao-Tian Wu; Xu-Han Shi; Wen-Bin Wei
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

6.  Identification of a prognostic model using cuproptosis-related genes in uveal melanoma.

Authors:  Yao Chen; Xiaozhen Chen; Xianggui Wang
Journal:  Front Cell Dev Biol       Date:  2022-08-30

7.  Analysis of local recurrence causes in uveal melanoma patients treated with 125I brachytherapy - a single institution study.

Authors:  Joanna Kowal; Anna Markiewicz; Magdalena Dębicka-Kumela; Anna Bogdali; Barbara Jakubowska; Izabella Karska-Basta; Bożena Romanowska-Dixon
Journal:  J Contemp Brachytherapy       Date:  2019-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.